A funding masterclass for Wales' innovation community. With 2026/27 and new funding opportunities on the horizon, join this session hosted by Life Sciences Hub Wales in partnership with the Academy of Medical Sciences, for a bid writing master class. Whether you're new to funding applications or ready for a refresher, this session offers practical tips, insights into live funding calls…
The UK is a Horizon Europe Associated Country, so UK organisations can participate as beneficiaries and as coordinators – although occasional restrictions may apply to a particular calls/call topics. The webinar will give a brief introduction to Horizon Europe. It will then cover the Horizon Europe research and innovation funding opportunities related to Health, including from the Health Work Programme,…
Advancing site readiness for CAR-T delivery in autoimmune indications | Case studies with practical insights. Over recent years, there has been rapid growth in the clinical development pipeline for CAR T therapies in autoimmune indications. These trials introduce new and complex challenges for the sector, including the need for shared care delivery pathways and coordinated clinical infrastructure. To ensure the…
Perfusion intensification, cold harvest stabilization, and inline affinity capture together can more than double lentiviral vector (LVV) recovery while removing steps from the process. This session presents a continuous LVV workflow that reached around 12 × 10⁶ viable cells/mL before transfection and delivered roughly 16-fold higher cumulative transduction units over 3 days through cold harvest handling. Keen Chung, Technical Lead…
This webinar explores the scientific and analytical capabilities required to support precision medicine programs across advanced modalities such as cell and gene therapy, and complex therapeutic areas, including oncology and neurology. Join an expert panel as they explore key considerations in potency assessment, safety monitoring and evidence generation, with a focus on building integrated strategies that support development from early…
Serum is one of the largest sources of variability in T cell manufacturing, driving lot-to-lot inconsistency, sourcing constraints, and contamination risk. This data-led session shows you how a chemically defined, serum-free workflow removes that dependency, so you can build more reproducible processes from early development through clinical scale. Chengkang Zhang will walk through experimental data on the impact of serum…